Valeriya Akhtyamovna Bandovkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valeriya Akhtyamovna Bandovkina has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
- Elena Mikhaylovna Frantsiyants
National Medical Research Center of Oncology, Ministry of Health of Russia
88 shared publications - Irina Valer'EVna Neskubina
National Medical Research Center of Oncology, Ministry of Health of Russia
57 shared publications - Ekaterina Igorevna Surikova
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
56 shared publications - Irina Viktorovna Kaplieva
Rostov Research Institute of Oncology
52 shared publications - Natal'YA Dmitrievna Cheryarina
National Medical Research Center of Oncology, Ministry of Health of Russia
44 shared publications - Lidiya Konstantinovna Trepitaki
National Medical Research Center for Oncology, Ministry of Health of Russia
39 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Adrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Open AccessAdrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- Open Access
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Adrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Open AccessAdrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- Open Access
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 49-66
Morphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus
Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 49-66
Open AccessMorphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus
Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.
- Open Access
- 18 September 2026
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 13 (3) , 8-19
The genes copy number variation features in blood plasma of uterine cancer patients and disease prognosis
Introduction. Uterine cancer is a leading gynecologic oncology morbidity. Early prediction of metastatic disease is critical for treatment decisions. Therefore, the search for minimally invasive molecular markers for predicting metastasis is a pressing issue. Promising biomarkers in this regard include gene copy number values in circulating cell-free DNA (cfDNA) in plasma. Aim. To analyze the relative copy number of genes regulating mitochondrial function in plasma of uterine cancer patients to develop a minimally invasive method for predicting metastasis. Materials and methods. The bioinformatics phase of the study identified a list of genes associated with mitochondrial dysfunction and abnormal copy number in uterine cancer. The study included 98 patients diagnosed with adenocarcinoma of the corpus uteri (G1 (n = 43), G2 (n = 35) and G3 (n = 20)), 15 patients with uterine myoma and 20 conditionally healthy donors. The relative copy number of 13 genes was determined by quantitative real-time polymerase chain reaction on cfDNA samples from blood plasma. ROC analysis and LASSO-penalized (LASSO – Least Absolute Shrinkage and Selection Operator) logistic regression were used to select markers. Results. A significant decrease in relative copy number of mtSSB, MT-RNR2, NRF1, MGME1, and MT-CO1 in plasma was revealed in uterine cancer patients (p 0.005) with a metastatic course of the disease, moreover, the degree of change in copy number increased from G1 to G3. LASSO regression analysis enabled the selection of three genes: mtSSB, MT-RNR2, and MGME1. The combined panel achieved an area under the curve (AUC) of 0.98 (95 % confidence interval 0.96–1.00), a sensitivity of 95 %, and a specificity of 92 % for predicting metastases. Conclusion. Thus, determination of the copy number of the mtSSB, MT-RNR2 and MGME1 genes in blood plasma has potential for use in minimally invasive prediction of metastatic lesions in uterine cancer.
- 18 September 2026
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 13 (3) , 8-19
Open AccessThe genes copy number variation features in blood plasma of uterine cancer patients and disease prognosis
Introduction. Uterine cancer is a leading gynecologic oncology morbidity. Early prediction of metastatic disease is critical for treatment decisions. Therefore, the search for minimally invasive molecular markers for predicting metastasis is a pressing issue. Promising biomarkers in this regard include gene copy number values in circulating cell-free DNA (cfDNA) in plasma. Aim. To analyze the relative copy number of genes regulating mitochondrial function in plasma of uterine cancer patients to develop a minimally invasive method for predicting metastasis. Materials and methods. The bioinformatics phase of the study identified a list of genes associated with mitochondrial dysfunction and abnormal copy number in uterine cancer. The study included 98 patients diagnosed with adenocarcinoma of the corpus uteri (G1 (n = 43), G2 (n = 35) and G3 (n = 20)), 15 patients with uterine myoma and 20 conditionally healthy donors. The relative copy number of 13 genes was determined by quantitative real-time polymerase chain reaction on cfDNA samples from blood plasma. ROC analysis and LASSO-penalized (LASSO – Least Absolute Shrinkage and Selection Operator) logistic regression were used to select markers. Results. A significant decrease in relative copy number of mtSSB, MT-RNR2, NRF1, MGME1, and MT-CO1 in plasma was revealed in uterine cancer patients (p 0.005) with a metastatic course of the disease, moreover, the degree of change in copy number increased from G1 to G3. LASSO regression analysis enabled the selection of three genes: mtSSB, MT-RNR2, and MGME1. The combined panel achieved an area under the curve (AUC) of 0.98 (95 % confidence interval 0.96–1.00), a sensitivity of 95 %, and a specificity of 92 % for predicting metastases. Conclusion. Thus, determination of the copy number of the mtSSB, MT-RNR2 and MGME1 genes in blood plasma has potential for use in minimally invasive prediction of metastatic lesions in uterine cancer.
- Open Access
- 6 September 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (3) , 45-59
Sexual dimorphism of the mitochondrial steroid profile in metastatic rectal cancer
Purpose of the study. To determine the sex-specific features of the content of steroid hormones and their receptors in mitochondria isolated from tumor tissue and the resection line in patients with rectal cancer (RC), depending on the presence or absence of metastases. Patients and methods . The study included 48 patients with RC: 24 men and 24 women. In each group, 12 patients had a localized form (stage T2–3N0M0) and 12 had a metastatic form (stage T2–3N1M0). The groups (men/women, with/without metastases) were comparable in age. The median patient age was 66 (range 58–73) years. Mitochondria were isolated from tumor cells and the resection line of the rectum by differential centrifugation. The levels of estradiol (E2), estrone (E1), free estriol (fE3), testosterone (T), progesterone (P4), cortisol, cholesterol, and receptors (ERα, ERβ, RA, RP4) were determined using ELISA kits (Cusabio, China). Statistical analysis was performed using Statistica 10 software. Results . Opposite sex-dependent changes in the hormonal profile during metastasis were established. In men with metastases, mitochondrial levels of testosterone, cholesterol, and receptors (RA, RP4, ERα) were 1.7–4.5‑fold higher, while free estriol was 1.6‑fold lower. In women, metastases were associated with a 2.5–9.6‑fold decrease in mitochondrial testosterone, ERα, and ERβ levels against a background of a 2.3‑fold increase in free estriol and an 8‑fold increase in cholesterol. In mitochondria from the resection line, the metastatic process partially neutralized the initial sex differences. Conclusion . In metastatic RC, opposite programs of mitochondrial adaptation are activated in men and women. In women, metastasis is associated with a decrease in androgen and estrogen signaling against a background of high estriol, while in men, it is linked to the enhancement of the androgen pathway and synthetic processes. A partial leveling of sex differences in the steroid profile of the resection line is observed, reflecting a systemic metabolic reprogramming that supports an aggressive tumor phenotype. The study findings suggest that mitochondrial biomarkers may have potential for predicting the development of RC; however, further validation in clinical studies is required.
- 6 September 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (3) , 45-59
Open AccessSexual dimorphism of the mitochondrial steroid profile in metastatic rectal cancer
Purpose of the study. To determine the sex-specific features of the content of steroid hormones and their receptors in mitochondria isolated from tumor tissue and the resection line in patients with rectal cancer (RC), depending on the presence or absence of metastases. Patients and methods . The study included 48 patients with RC: 24 men and 24 women. In each group, 12 patients had a localized form (stage T2–3N0M0) and 12 had a metastatic form (stage T2–3N1M0). The groups (men/women, with/without metastases) were comparable in age. The median patient age was 66 (range 58–73) years. Mitochondria were isolated from tumor cells and the resection line of the rectum by differential centrifugation. The levels of estradiol (E2), estrone (E1), free estriol (fE3), testosterone (T), progesterone (P4), cortisol, cholesterol, and receptors (ERα, ERβ, RA, RP4) were determined using ELISA kits (Cusabio, China). Statistical analysis was performed using Statistica 10 software. Results . Opposite sex-dependent changes in the hormonal profile during metastasis were established. In men with metastases, mitochondrial levels of testosterone, cholesterol, and receptors (RA, RP4, ERα) were 1.7–4.5‑fold higher, while free estriol was 1.6‑fold lower. In women, metastases were associated with a 2.5–9.6‑fold decrease in mitochondrial testosterone, ERα, and ERβ levels against a background of a 2.3‑fold increase in free estriol and an 8‑fold increase in cholesterol. In mitochondria from the resection line, the metastatic process partially neutralized the initial sex differences. Conclusion . In metastatic RC, opposite programs of mitochondrial adaptation are activated in men and women. In women, metastasis is associated with a decrease in androgen and estrogen signaling against a background of high estriol, while in men, it is linked to the enhancement of the androgen pathway and synthetic processes. A partial leveling of sex differences in the steroid profile of the resection line is observed, reflecting a systemic metabolic reprogramming that supports an aggressive tumor phenotype. The study findings suggest that mitochondrial biomarkers may have potential for predicting the development of RC; however, further validation in clinical studies is required.
- 21 August 2026
- Published by Publishing House ABV Press in MD-Onco
- Vol. 6 (2) , 57-65
Dynamics of pituitary hormone levels in adolescents with acute lymphoblastic leukemia before and after chemotherapy
Background. Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in children. Modern treatment protocols have achieved high survival rates, increasing the significance of investigating early and late therapy-related complications, including endocrine disorders. Dysfunction of the hypothalamic-pituitary axis may develop both during antitumor therapy and prior to its initiation; however, data on the dynamics of pituitary hormone levels in adolescents with ALL remain limited. Aim. To assess blood levels of pituitary hormones – including luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, growth hormone (GH), adrenocorticotropic hormone (ACTH), and thyroid-stimulating hormone (TSH) – in adolescents with ALL before treatment initiation and after completion of therapy. Materials and methods. The study included 40 adolescents of both sexes with ALL (median age 14.55 (11–17) years). The control group consisted of 40 age- and sex-matched apparently healthy children (median age 15.25 (11–17) years). Pituitary hormone levels (LH, FSH, prolactin, GH, ACTH, and TSH) were measured in blood samples before treatment and after the third consolidation phase using standard radioimmunoassay and enzyme-linked immunosorbent assay kits. Mean hormone levels obtained from the control group were used as reference values. Statistical analysis was performed using Statistica 10 software. Results. In girls before treatment, the levels of LH, FSH, and TSH, as well as the LH/FSH ratio, were within the reference range (p 0.05). Prolactin level was elevated 2.9-fold (p 0.05), whereas GH and ACTH levels were reduced 2.5- and 1.8-fold, respectively (p 0.05). After the third consolidation phase, LH and FSH levels increased relative to both the baseline and reference values: LH by factors of 2.1 and 1.6, and FSH by factors of 2.3 and 2.2, respectively (p 0.05). The LH/FSH ratio remained within the reference range. Prolactin level remained elevated, exceeding the reference range by a factor of 2.0 (p 0.05). GH level increased 1.5-fold compared to the baseline (p 0.05) but remained 1.6-fold lower than the reference range (p 0.05). ACTH levels increased 2.1-fold (p 0.05) and reached the reference values. TSH levels remained within the reference range. In boys, LH levels were reduced 1.5-fold before treatment (p 0.05), while FSH levels and the LH/FSH ratio were within the reference range. Prolactin level was elevated 1.8-fold (p 0.05), and GH level was elevated 3.0-fold (p 0.05). ACTH and TSH levels showed 1.7-fold decrease each (p 0.05). After the third consolidation phase, LH levels normalized, increasing 1.6-fold (p 0.05). FSH level increased 1.8-fold relative to the baseline (p 0.05) and remained within the reference range. The LH/FSH ratio remained normal. Prolactin level increased 1.6-fold compared to the baseline (p 0.05) and exceeded the reference range by a factor of 2.9 (p 0.05). GH level decreased 4.3-fold relative to the baseline (p 0.05) and was 1.4-fold below the reference values (p 0.05). ACTH and TSH levels increased by factors of 2.2 and 1.8, respectively (p 0.05), reaching the reference values. Conclusion. ALL in adolescents is associated with dysfunction of the adenohypophysis and an imbalance of tropic hormones, with the direction and magnitude of changes depending on sex and treatment stage. Antitumor therapy rarely results in complete normalization of pituitary hormone levels, which is attributable to both the disease itself and the cytotoxic effects of treatment. These findings support the need for dynamic monitoring of LH, FSH, prolactin, GH, ACTH, and TSH levels in adolescents with ALL at all stages of therapy for early detection and timely correction of endocrine disorders.
- 21 August 2026
- Published by Publishing House ABV Press in MD-Onco
- Vol. 6 (2) , 57-65
Dynamics of pituitary hormone levels in adolescents with acute lymphoblastic leukemia before and after chemotherapy
Background. Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in children. Modern treatment protocols have achieved high survival rates, increasing the significance of investigating early and late therapy-related complications, including endocrine disorders. Dysfunction of the hypothalamic-pituitary axis may develop both during antitumor therapy and prior to its initiation; however, data on the dynamics of pituitary hormone levels in adolescents with ALL remain limited. Aim. To assess blood levels of pituitary hormones – including luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, growth hormone (GH), adrenocorticotropic hormone (ACTH), and thyroid-stimulating hormone (TSH) – in adolescents with ALL before treatment initiation and after completion of therapy. Materials and methods. The study included 40 adolescents of both sexes with ALL (median age 14.55 (11–17) years). The control group consisted of 40 age- and sex-matched apparently healthy children (median age 15.25 (11–17) years). Pituitary hormone levels (LH, FSH, prolactin, GH, ACTH, and TSH) were measured in blood samples before treatment and after the third consolidation phase using standard radioimmunoassay and enzyme-linked immunosorbent assay kits. Mean hormone levels obtained from the control group were used as reference values. Statistical analysis was performed using Statistica 10 software. Results. In girls before treatment, the levels of LH, FSH, and TSH, as well as the LH/FSH ratio, were within the reference range (p 0.05). Prolactin level was elevated 2.9-fold (p 0.05), whereas GH and ACTH levels were reduced 2.5- and 1.8-fold, respectively (p 0.05). After the third consolidation phase, LH and FSH levels increased relative to both the baseline and reference values: LH by factors of 2.1 and 1.6, and FSH by factors of 2.3 and 2.2, respectively (p 0.05). The LH/FSH ratio remained within the reference range. Prolactin level remained elevated, exceeding the reference range by a factor of 2.0 (p 0.05). GH level increased 1.5-fold compared to the baseline (p 0.05) but remained 1.6-fold lower than the reference range (p 0.05). ACTH levels increased 2.1-fold (p 0.05) and reached the reference values. TSH levels remained within the reference range. In boys, LH levels were reduced 1.5-fold before treatment (p 0.05), while FSH levels and the LH/FSH ratio were within the reference range. Prolactin level was elevated 1.8-fold (p 0.05), and GH level was elevated 3.0-fold (p 0.05). ACTH and TSH levels showed 1.7-fold decrease each (p 0.05). After the third consolidation phase, LH levels normalized, increasing 1.6-fold (p 0.05). FSH level increased 1.8-fold relative to the baseline (p 0.05) and remained within the reference range. The LH/FSH ratio remained normal. Prolactin level increased 1.6-fold compared to the baseline (p 0.05) and exceeded the reference range by a factor of 2.9 (p 0.05). GH level decreased 4.3-fold relative to the baseline (p 0.05) and was 1.4-fold below the reference values (p 0.05). ACTH and TSH levels increased by factors of 2.2 and 1.8, respectively (p 0.05), reaching the reference values. Conclusion. ALL in adolescents is associated with dysfunction of the adenohypophysis and an imbalance of tropic hormones, with the direction and magnitude of changes depending on sex and treatment stage. Antitumor therapy rarely results in complete normalization of pituitary hormone levels, which is attributable to both the disease itself and the cytotoxic effects of treatment. These findings support the need for dynamic monitoring of LH, FSH, prolactin, GH, ACTH, and TSH levels in adolescents with ALL at all stages of therapy for early detection and timely correction of endocrine disorders.
- 23 June 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (2) , 67-78
The copy number variations of genes regulating mitochondrial function in benign and malignant uterine body neoplasms
Purpose of the study. To study changes in the copy number of genes whose products are involved in maintaining the structure and function of mitochondria in tissues of benign neoplasms and endometrioid adenocarcinoma (EA) of the uterine body of varying degrees of differentiation. Materials and methods. The study utilized tumor tissue and normal uterine tissue from 42 patients with endometrioid adenocarcinoma (EA) and 15 patients with uterine fibroids. The tumor burden in the EA patients was between stages Ia and Ib, and neoadjuvant treatment was not administered. DNA was isolated from tumor and normal uterine tissue fragments using phenol-chloroform extraction, and relative gene copy numbers were determined using real-time PCR (real-time qPCR). Statistical analysis was performed using the Mann-Whitney U-test with a Bonferroni correction. Results. In patients with EA G1, a decrease in the copy number of nuclear and mitochondrial genes was observed (MT-CO1 = 0.5, mtTFB = 0.4, mtSSB = 0.6, MT-RNR2 = 0.3, NRF1 = 0.4) (p < 0.005) and an increase in the copy number of MGME1 (2.4) (p < 0.005). In patients with EA G2, a picture similar to G1 is observed: a decrease in the copy number of the genes MT-CO1; mtTFB, MT-RNR2 and NRF1 (p < 0.005), except for mtSSB. An increase in the copy number of MGME1 (3.1) and POLRMT (1.8) (p < 0.005) was also recorded. In patients with EA G3, the most pronounced decrease in the copy number of mtSSB and MT-RNR2 by 5.0 times relative to normal tissue was found, as well as a decrease in the copy number of MGME1 by 3.3 times, which is the opposite of the results in G1/G2. Conclusion. Significant differences in the copy number of genes involved in mitochondrial function were identified between benign uterine tissues and endometrioid adenocarcinoma. The most prominent alterations included reduced copy numbers of key mitochondrial genes (MT-CO1 and MT-RNR2), the nuclear gene mtSSB, and aberrant MGME1 copy number changes in tumor tissues. These findings provide new insights into the molecular mechanisms underlying endometrioid adenocarcinoma development and may contribute to the identification of potential diagnostic and prognostic biomarkers.
- 23 June 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (2) , 67-78
The copy number variations of genes regulating mitochondrial function in benign and malignant uterine body neoplasms
Purpose of the study. To study changes in the copy number of genes whose products are involved in maintaining the structure and function of mitochondria in tissues of benign neoplasms and endometrioid adenocarcinoma (EA) of the uterine body of varying degrees of differentiation. Materials and methods. The study utilized tumor tissue and normal uterine tissue from 42 patients with endometrioid adenocarcinoma (EA) and 15 patients with uterine fibroids. The tumor burden in the EA patients was between stages Ia and Ib, and neoadjuvant treatment was not administered. DNA was isolated from tumor and normal uterine tissue fragments using phenol-chloroform extraction, and relative gene copy numbers were determined using real-time PCR (real-time qPCR). Statistical analysis was performed using the Mann-Whitney U-test with a Bonferroni correction. Results. In patients with EA G1, a decrease in the copy number of nuclear and mitochondrial genes was observed (MT-CO1 = 0.5, mtTFB = 0.4, mtSSB = 0.6, MT-RNR2 = 0.3, NRF1 = 0.4) (p < 0.005) and an increase in the copy number of MGME1 (2.4) (p < 0.005). In patients with EA G2, a picture similar to G1 is observed: a decrease in the copy number of the genes MT-CO1; mtTFB, MT-RNR2 and NRF1 (p < 0.005), except for mtSSB. An increase in the copy number of MGME1 (3.1) and POLRMT (1.8) (p < 0.005) was also recorded. In patients with EA G3, the most pronounced decrease in the copy number of mtSSB and MT-RNR2 by 5.0 times relative to normal tissue was found, as well as a decrease in the copy number of MGME1 by 3.3 times, which is the opposite of the results in G1/G2. Conclusion. Significant differences in the copy number of genes involved in mitochondrial function were identified between benign uterine tissues and endometrioid adenocarcinoma. The most prominent alterations included reduced copy numbers of key mitochondrial genes (MT-CO1 and MT-RNR2), the nuclear gene mtSSB, and aberrant MGME1 copy number changes in tumor tissues. These findings provide new insights into the molecular mechanisms underlying endometrioid adenocarcinoma development and may contribute to the identification of potential diagnostic and prognostic biomarkers.
- 23 June 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (2) , 34-46
Features of steroid hormone and receptor content in the mitochondria of endometrial adenocarcinoma according to tumor differentiation grade and the presence of type 2 diabetes mellitus
Mitochondria play a key role in cellular metabolism, steroid hormone synthesis, and the regulation of redox homeostasis. However, the role of mitochondrial steroidogenesis in the progression of endometrial adenocarcinoma (EA), particularly in the presence of type 2 diabetes mellitus (T2DM), remains poorly understood. Purpose of the study. To determine the concentrations of steroid hormones and their receptors in the mitochondrial fraction of G1–G3 endometrial adenocarcinoma tissue compared with intact endometrium and to evaluate the modifying effect of type 2 diabetes mellitus on these parameters. Patients and methods. Mitochondria were isolated by differential centrifugation from tumor tissue obtained from 92 patients with endometrial adenocarcinoma (G1–G3) and from morphologically normal endometrium (control group). Standard enzyme-linked immunosorbent assay (ELISA) kits were used to determine the concentrations of estradiol (E2), estriol (E3), estrone (E1) and their receptors (ERα, ERβ), testosterone (T) and the androgen receptor (AR), progesterone (P4) and the progesterone receptor (PR), as well as cortisol and cholesterol. Statistical analysis was performed using Statistica 10 software. Results. In the mitochondria of G1–G2 endometrial adenocarcinomas, the estradiol level was approximately twofold higher than in the control group, whereas G3 tumors demonstrated an approximately twofold increase in estriol concentration. Testosterone and cortisol levels were elevated in the mitochondria of all tumors by 1.6-fold and more than twofold, respectively. Progesterone content was increased by 2.3–3.8-fold in the mitochondria of G1–G2 tumors but decreased by 4.3–5.9-fold in comparison with the control mitochondria. The levels of androgen and estrogen receptors were elevated in the mitochondria of all tumors, whereas the ERα/ERβ ratio decreased by 1.7–3.6-fold. Progesterone receptor levels were increased in G1–G2 mitochondria only in patients with T2DM, whereas in G3 tumors they were elevated regardless of T2DM status. Type 2 diabetes mellitus was associated with cholesterol accumulation in the mitochondria of all tumors. Conclusion. Regardless of tumor differentiation grade and the presence of type 2 diabetes mellitus, endometrial adenocarcinoma mitochondria are characterized by increased levels of testosterone, cortisol, and sex hormone receptors, reflecting profound metabolic reprogramming of these organelles. Estradiol predominates in G1–G2 tumors, whereas estriol is the dominant estrogen in G3 tumors, which may contribute to increased tumor aggressiveness. Type 2 diabetes mellitus is associated with mitochondrial cholesterol accumulation, which may partly explain the more severe clinical course of endometrial adenocarcinoma in these patients.
- 23 June 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (2) , 34-46
Features of steroid hormone and receptor content in the mitochondria of endometrial adenocarcinoma according to tumor differentiation grade and the presence of type 2 diabetes mellitus
Mitochondria play a key role in cellular metabolism, steroid hormone synthesis, and the regulation of redox homeostasis. However, the role of mitochondrial steroidogenesis in the progression of endometrial adenocarcinoma (EA), particularly in the presence of type 2 diabetes mellitus (T2DM), remains poorly understood. Purpose of the study. To determine the concentrations of steroid hormones and their receptors in the mitochondrial fraction of G1–G3 endometrial adenocarcinoma tissue compared with intact endometrium and to evaluate the modifying effect of type 2 diabetes mellitus on these parameters. Patients and methods. Mitochondria were isolated by differential centrifugation from tumor tissue obtained from 92 patients with endometrial adenocarcinoma (G1–G3) and from morphologically normal endometrium (control group). Standard enzyme-linked immunosorbent assay (ELISA) kits were used to determine the concentrations of estradiol (E2), estriol (E3), estrone (E1) and their receptors (ERα, ERβ), testosterone (T) and the androgen receptor (AR), progesterone (P4) and the progesterone receptor (PR), as well as cortisol and cholesterol. Statistical analysis was performed using Statistica 10 software. Results. In the mitochondria of G1–G2 endometrial adenocarcinomas, the estradiol level was approximately twofold higher than in the control group, whereas G3 tumors demonstrated an approximately twofold increase in estriol concentration. Testosterone and cortisol levels were elevated in the mitochondria of all tumors by 1.6-fold and more than twofold, respectively. Progesterone content was increased by 2.3–3.8-fold in the mitochondria of G1–G2 tumors but decreased by 4.3–5.9-fold in comparison with the control mitochondria. The levels of androgen and estrogen receptors were elevated in the mitochondria of all tumors, whereas the ERα/ERβ ratio decreased by 1.7–3.6-fold. Progesterone receptor levels were increased in G1–G2 mitochondria only in patients with T2DM, whereas in G3 tumors they were elevated regardless of T2DM status. Type 2 diabetes mellitus was associated with cholesterol accumulation in the mitochondria of all tumors. Conclusion. Regardless of tumor differentiation grade and the presence of type 2 diabetes mellitus, endometrial adenocarcinoma mitochondria are characterized by increased levels of testosterone, cortisol, and sex hormone receptors, reflecting profound metabolic reprogramming of these organelles. Estradiol predominates in G1–G2 tumors, whereas estriol is the dominant estrogen in G3 tumors, which may contribute to increased tumor aggressiveness. Type 2 diabetes mellitus is associated with mitochondrial cholesterol accumulation, which may partly explain the more severe clinical course of endometrial adenocarcinoma in these patients.
- Open Access
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 6-22
The level of antioxidants, 8OHDG, and mitochondrial membrane potential of tumor tissues depending on the location of colorectal cancer
Purpose of the study. To study the mitochondrial membrane potential, indicators of the enzymatic and non-enzymatic antioxidant systems, and the mtDNA damage index in the mitochondria of colorectal cancer (CRC) cells depending on its location, the presence of metastases in the lymph nodes, and the patient sex. Patients and methods. The study included results obtained from 132 patients (52 women and 80 men) with T2–3N0M0 colon cancer. Mitochondria from intestinal and tumor tissue cells were isolated using differential centrifugation. The concentration of SOD-2, 8OHdG, vitamins A and E, GPO-1, and the membrane potential (ΔψM) were determined in mitochondria. Statistical analysis was performed using the program Statistica 10.0. Results. In rectal tumor mitochondria with lymph node metastases, both men and women demonstrated increased 8-OHdG levels and decreased ΔψM compared with patients without lymph node metastases: in men, by 2.2-fold and 1.5-fold (p < 0.05), and in women, by 1.3-fold (p < 0.05) and 2.0-fold, respectively. In the left colon, tumor mitochondria in men with metastases showed a 2.4-fold increase in 8-OHdG, while ΔψM and vitamins A and E levels were reduced by 1.7-fold (p < 0.05), 2.4-fold, and 3.1-fold, respectively. In women, lymph node metastases were associated with decreased levels of vitamins A and E by 1.7-fold (p < 0.05) and 4.3-fold. In the right colon, tumor mitochondria in patients with metastases showed higher levels of vitamins A and E compared with those without metastases: vitamin A increased by 1.7-fold (p < 0.05) in men and 2.4-fold in women, and vitamin E by 4.2-fold and 3.9-fold, respectively. SOD-2 levels were 2.2-fold lower only in tumor mitochondria with metastases in men.
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 6-22
Open AccessThe level of antioxidants, 8OHDG, and mitochondrial membrane potential of tumor tissues depending on the location of colorectal cancer
Purpose of the study. To study the mitochondrial membrane potential, indicators of the enzymatic and non-enzymatic antioxidant systems, and the mtDNA damage index in the mitochondria of colorectal cancer (CRC) cells depending on its location, the presence of metastases in the lymph nodes, and the patient sex. Patients and methods. The study included results obtained from 132 patients (52 women and 80 men) with T2–3N0M0 colon cancer. Mitochondria from intestinal and tumor tissue cells were isolated using differential centrifugation. The concentration of SOD-2, 8OHdG, vitamins A and E, GPO-1, and the membrane potential (ΔψM) were determined in mitochondria. Statistical analysis was performed using the program Statistica 10.0. Results. In rectal tumor mitochondria with lymph node metastases, both men and women demonstrated increased 8-OHdG levels and decreased ΔψM compared with patients without lymph node metastases: in men, by 2.2-fold and 1.5-fold (p < 0.05), and in women, by 1.3-fold (p < 0.05) and 2.0-fold, respectively. In the left colon, tumor mitochondria in men with metastases showed a 2.4-fold increase in 8-OHdG, while ΔψM and vitamins A and E levels were reduced by 1.7-fold (p < 0.05), 2.4-fold, and 3.1-fold, respectively. In women, lymph node metastases were associated with decreased levels of vitamins A and E by 1.7-fold (p < 0.05) and 4.3-fold. In the right colon, tumor mitochondria in patients with metastases showed higher levels of vitamins A and E compared with those without metastases: vitamin A increased by 1.7-fold (p < 0.05) in men and 2.4-fold in women, and vitamin E by 4.2-fold and 3.9-fold, respectively. SOD-2 levels were 2.2-fold lower only in tumor mitochondria with metastases in men.
- Open Access
- 20 March 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (1) , 31-43
Features of mitochondrial hormone and receptor levels in aggressive endometrial cancer subtypes
Serous endometrial carcinoma (SEC) and clear cell endometrial carcinoma (CCEC) are among the most aggressive subtypes of endometrial cancer (EC), characterized by a high risk of recurrence and metastasis. Mitochondria play a key role in steroidogenesis and cellular metabolism; however, their contribution to hormonal and metabolic tumor adaptation in rare forms of EC remains poorly understood. Purpose of the study . To comprehensively assess the levels of sex hormones, their receptors, cortisol, and glutathione in mitochondria isolated from SEC and CCEC tissues.Patients and methods. This prospective study included 41 patients with rare forms of EC. Mitochondria were isolated from tumor tissues – 21 SEC and 20 CCEC. The control group was composed of 20 samples of endometrium unaffected by tumour. Concentrations of estrone, estradiol, estriol, testosterone, progesterone, estrogen receptors (REα, REβ), androgen receptors, progesterone receptors (RP4), cortisol, cholesterol, and glutathione were determined by enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using Statistica 10.0 software. Results . In mitochondria obtained from SEC and CCEC, compared with tumor-free endometrial mitochondria, levels of testosterone and progesterone were increased by an average of 1.5‑fold, estriol by 1.8‑fold and 2.2‑fold, REβ by 3.5‑fold and 1.8‑fold, RP4 by 2.4‑fold and 5.2‑fold, and the REβ/REα ratio by 2.2‑fold and 1.9‑fold, respectively. Estradiol, REα, and androgen receptor levels exceeded control values only in SEC mitochondria, by 2.0‑fold, 1.8‑fold, and 2.2‑fold, respectively. Cortisol and cholesterol concentrations in mitochondria from rare endometrial cancer subtypes were 1.9–2.5‑fold higher than in tumor-free endometrial mitochondria, while glutathione levels were increased by 1.9–2.4‑fold. Conclusion . SEC and CCEC are characterized by the formation of a unique mitochondrial hormonal microenvironment with estriol predominance and a high REβ/REα ratio, which may mediate suppression of apoptosis and enhanced proliferation. Differences in receptor profiles indicate distinct mechanisms of hormonal signaling, potentially determining specific features of the clinical course of each tumor subtype. Accumulation of cholesterol and cortisol in the context of elevated glutathione levels indicates metabolic reprogramming aimed at sustaining steroidogenesis and resistance to oxidative stress and apoptosis.
- 20 March 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (1) , 31-43
Open AccessFeatures of mitochondrial hormone and receptor levels in aggressive endometrial cancer subtypes
Serous endometrial carcinoma (SEC) and clear cell endometrial carcinoma (CCEC) are among the most aggressive subtypes of endometrial cancer (EC), characterized by a high risk of recurrence and metastasis. Mitochondria play a key role in steroidogenesis and cellular metabolism; however, their contribution to hormonal and metabolic tumor adaptation in rare forms of EC remains poorly understood. Purpose of the study . To comprehensively assess the levels of sex hormones, their receptors, cortisol, and glutathione in mitochondria isolated from SEC and CCEC tissues.Patients and methods. This prospective study included 41 patients with rare forms of EC. Mitochondria were isolated from tumor tissues – 21 SEC and 20 CCEC. The control group was composed of 20 samples of endometrium unaffected by tumour. Concentrations of estrone, estradiol, estriol, testosterone, progesterone, estrogen receptors (REα, REβ), androgen receptors, progesterone receptors (RP4), cortisol, cholesterol, and glutathione were determined by enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using Statistica 10.0 software. Results . In mitochondria obtained from SEC and CCEC, compared with tumor-free endometrial mitochondria, levels of testosterone and progesterone were increased by an average of 1.5‑fold, estriol by 1.8‑fold and 2.2‑fold, REβ by 3.5‑fold and 1.8‑fold, RP4 by 2.4‑fold and 5.2‑fold, and the REβ/REα ratio by 2.2‑fold and 1.9‑fold, respectively. Estradiol, REα, and androgen receptor levels exceeded control values only in SEC mitochondria, by 2.0‑fold, 1.8‑fold, and 2.2‑fold, respectively. Cortisol and cholesterol concentrations in mitochondria from rare endometrial cancer subtypes were 1.9–2.5‑fold higher than in tumor-free endometrial mitochondria, while glutathione levels were increased by 1.9–2.4‑fold. Conclusion . SEC and CCEC are characterized by the formation of a unique mitochondrial hormonal microenvironment with estriol predominance and a high REβ/REα ratio, which may mediate suppression of apoptosis and enhanced proliferation. Differences in receptor profiles indicate distinct mechanisms of hormonal signaling, potentially determining specific features of the clinical course of each tumor subtype. Accumulation of cholesterol and cortisol in the context of elevated glutathione levels indicates metabolic reprogramming aimed at sustaining steroidogenesis and resistance to oxidative stress and apoptosis.